Methods for increasing observed editing in bacteria

Patent metadata

Field	Value
Publication number	US-11891609-B2
Application number	US-202217680289-A
Country	US
Kind code	B2
Filing date	Feb 25, 2022
Priority date	Nov 19, 2019
Publication date	Feb 6, 2024
Grant date	Feb 6, 2024

Abstract

The present disclosure relates to methods for increasing observed editing rates in the surviving bacteria cells. The compositions and methods presented herein in combination lead to a phenomenon of “edit or die.” Although less cells survive plating and editing, a large percentage of cells that do survive are multiple editors. In one experiment it was found that if a cell survives transformation, plating, and editing, 75% of the surviving cells are multiple editors; that is, 75% of the surviving cells were simultaneously edited with edits at two or more different locations within the bacterial genome.

First claim

We claim:

1. A method for increasing observed editing in a multiplexed CRISPR nuclease editing system in bacteria comprising:
(a) providing bacteria cells, wherein each of the bacteria cells comprises
(i) an engine vector comprising:
(A) a first inducible promoter driving expression of a coding sequence for a CRISPR nuclease;
(B) a bacterial origin of replication; and
(C) a first selection marker; and

(ii) an editing vector comprising a second inducible promoter or a constitutive promoter driving expression of a coding sequence for a recA protein, wherein the second inducible promoter or the constitutive promoter drives transcription of at least two editing cassettes, wherein each editing cassette comprises:
(A) a gRNA sequence and a donor DNA sequence to be transcribed;
(B) a bacterial origin or replication; and
(C) a second selection marker;

(b) allowing transcription of the recA protein and the at least two editing cassettes from the second inducible promoter or the constitutive promoter; and
(c) following transcription of the recA protein and the at least two editing cassettes, inducing transcription of the CRISPR nuclease to produce edited cells.

2. The method of claim 1 , wherein the CRISPR nuclease is MAD7.

3. The method of claim 1 , wherein the CRISPR nuclease is Cas9.

4. The method of claim 1 , wherein the coding sequence for the recA protein is a coding sequence for a recA fusion protein.

5. The method of claim 4 , wherein the recA fusion protein is a recA-srpR fusion protein.

6. The method of claim 5 , wherein the recA-srpR fusion protein comprises an in-frame fusion protein comprising a coding sequence of the srpR protein at an N-terminal portion of the in-frame fusion protein and the coding sequence for the recA protein coding sequence at a C-terminal portion of the in-frame fusion protein.

7. The method of claim 1 , wherein the engine vector comprises a coding sequence for c1857 and the inducible promoter is a pL promoter driving expression of the CRISPR nuclease.

8. The method of claim 1 , wherein the engine vector further comprises coding sequences for a λRed recombineering system.

9. The method of claim 1 , wherein the second inducible promoter is a pL inducible promoter.

10. The method of claim 1 , wherein the first and second selection markers are different selection markers.

11. The method of claim 1 , wherein the method further comprises:
(d) providing to the edited cells:
a second editing vector comprising the second inducible promoter or the constitutive promoter driving expression of a coding sequence for a recA protein, wherein the second inducible promoter or the constitutive promoter drives transcription of at least two editing cassettes, wherein each editing cassette comprises:
(A) a gRNA sequence and a donor DNA sequence to be transcribed;
(B) a bacterial origin or replication; and
(C) a third selection marker;

(e) allowing transcription of the recA protein and the at least two editing cassettes from the second inducible promoter or the constitutive promoter; and
(f) following transcription of the recA protein and the at least two editing cassettes, inducing transcription of the CRISPR nuclease to produce twice edited cells.

12. A method for increasing observed editing in a multiplexed CRISPR nuclease editing system in bacteria comprising:
(A) providing bacteria cells, wherein each of the bacteria cells comprises:
(i) an engine vector comprising:
(a) a first inducible promoter driving expression of a coding sequence for a CRISPR nuclease;
(b) a bacterial origin of replication;
(c) a λRed recombineering system; and
(d) a first selection marker;

(ii) an editing vector comprising:
(a) a second inducible promoter or a constitutive promoter driving expression of a coding sequence for a recA protein;
(b) the second inducible promoter or the constitutive promoter driving transcription of at least two editing cassettes wherein each editing cassette comprises a gRNA sequence and a donor DNA sequence to be transcribed;
(c) a bacterial origin or replication; and
(d) a second selection marker;

(B) allowing transcription of the recA protein and the at least two editing cassettes from the second inducible promoter or the constitutive promoter; and
(C) following transcription of the recA protein and the at least two editing cassettes, inducing transcription of the CRISPR nuclease to produce edited cells.

13. The method of claim 12 , wherein the CRISPR nuclease is MAD7.

14. The method of claim 12 , wherein the CRISPR nuclease is Cas9.

15. The method of claim 12 , wherein the coding sequence for the recA protein is a coding sequence for a recA fusion protein.

16. The method of claim 15 , wherein the recA fusion protein is a recA-srpR fusion protein.

17. The method of claim 16 , wherein the recA-srpR fusion protein comprises an in-frame fusion protein comprising a coding sequence of the srpR protein at an N-terminal portion of the in-frame fusion protein and the coding sequence for the recA protein coding sequence at a C-terminal portion of the in-frame fusion protein.

18. The method of claim 12 , wherein the engine vector comprises a coding sequence for c1857 and an inducible pL promoter drives expression of the CRISPR nuclease and the at least two editing cassettes.

19. The method of claim 12 , wherein the first and second selection markers are different selection markers.

20. The method of claim 12 , wherein the method further comprises: (D) growing the edited cells in colonies until the cell colonies become normalized to produce normalized cells; and (E) pooling the normalized cells.

Assignees

• Inscripta Inc

Inventors

• Tian Tian
• Spindler Eileen
• Johnson Charles
• Davis Clint

Classifications

• C12N15/74 Primary

  Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora · CPC title

• C12N1/20

  Bacteria; Culture media therefor · CPC title

• C12N9/22 Primary

  Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

• C12N15/113

  Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

• C12N2310/20

  involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title